Form 4: HealthStream Director Deborah Taylor Tate Reports Stock Vesting

Director Deborah Taylor Tate reported the vesting of restricted share units into 1,125 shares of HealthStream Inc. common stock on June 6, 2024.

Summary

• On June 6, 2024, Deborah Taylor Tate, a director of HealthStream Inc. (HSTM), reported a transaction involving the vesting of restricted share units (RSUs).
• The transaction resulted in the acquisition of 1,125 shares of common stock upon the vesting of these RSUs.
• The price per share for the vesting was $0, as it represents the conversion of previously granted equity.
• Following the transaction, Ms. Tate directly owns 23,726 shares of HealthStream Inc. common stock and 2,252 restricted share units.
• The RSUs are subject to a three-year vesting schedule, with annual vesting beginning on June 6, 2024, contingent upon continued service.

Sentiment

Score: 6

Explanation: The document is a standard regulatory filing detailing an insider transaction. It doesn't contain overtly positive or negative information, but the vesting of shares is generally a neutral to slightly positive signal as it aligns the director's interests with shareholders.

Positives

• The vesting of restricted share units indicates that Ms. Tate has met certain service requirements, aligning her interests with those of the shareholders.
• The increased share ownership demonstrates Ms. Tate's continued investment in HealthStream Inc.

Industry Context

This Form 4 filing is a routine disclosure related to insider transactions and is common for publicly traded companies. It provides transparency into the equity holdings and transactions of company directors.

Comparison to Industry Standards

• Equity compensation, such as restricted share units, is a common practice among publicly traded companies to incentivize and retain key personnel, including directors.
• Vesting schedules, like the three-year annual vesting described in the document, are standard in the industry to ensure continued service and alignment of interests.
• Comparable companies in the healthcare technology sector, such as Cerner (now Oracle Health) and Allscripts Healthcare Solutions, also utilize equity compensation as part of their overall compensation packages for directors and executives.

Stakeholder Impact

• The vesting of shares has a minor positive impact on shareholders as it aligns the director's interests with the company's performance.

Key Dates